The patented PhytoVec® technology: a revolution in the encapsulation of plant-based active ingredients
Experts in technologies derived from pharmaceutical research for the cosmetics industry, Laboratoires ERIGER have developed and patented PhytoVec®, an innovative encapsulation process using chlorophyll. This technology enables the encapsulation of unstable plant-based active ingredients within protective microcapsules, effectively shielding them from oxidation, light-induced degradation, and temperature fluctuations.
Thanks to PhytoVec®, active ingredients benefit from:
- Enhanced efficacy, with a high concentration of active compounds, controlled release, and improved skin penetration;
- Simplified formulation: the technology is water-dispersible, suitable for cold processing, and free from controversial preservatives such as BHT or BHA;
- Outstanding naturality, based on a molecule present in all chlorophyll-containing plants, compliant with ISO 16128 standards;
- Superior protection against oxidation, light degradation, and thermal changes.
Strengthening and expanding Groupe Berkem’s offering in the cosmetics market
Combining its expertise in plant-based chemistry with the PhytoVec® technology, Groupe Berkem now has the ability to perform micro-encapsulation in chlorophyll-derived products such as hydroalcoholic solutions and serums, further solidifying its position as a leading player in the market. The Group is also working to integrate certain products developed by Laboratoires ERIGER into its own cosmetics portfolio.
Through this strategic acquisition, Groupe Berkem strengthens its Health, Beauty & Nutrition business area, enriching its range of high value-added solutions to meet the growing market demand for naturality, innovation, and performance. This synergy will accelerate the development of new products and broaden the applications of the PhytoVec® technology beyond cosmetics, extending into the health and nutrition sectors.
